Welcome to our dedicated page for WEST IS BRANDS news (Ticker: WIBFF), a resource for investors and traders seeking the latest updates and insights on WEST IS BRANDS stock.
West Island Brands Inc. is a multi-faceted, innovative company operating in the Quebec cannabis space. With its subsidiary RoyalMax Biotechnology Canada Inc., the company holds various Health Canada licenses. The company recently announced changes in its auditors and closed a non-brokered private placement financing to enhance its financial position. West Island Brands is focused on expanding its international market presence and diversifying its revenue streams. For more information, visit the company's website.
West Island Brands Inc. has completed a non-brokered private placement financing of 2,051,282 units, raising $200,000. The financing includes common shares and warrants exercisable at $0.13 over two years. The proceeds will be used to address outstanding fees, prepare financial statements, and secure a revocation of a failure to file cease trade order. West Island is active in the Quebec cannabis sector through its subsidiary, RoyalMax Biotechnology Canada Inc. It holds various Health Canada licenses and distributes products across multiple Canadian provinces.